These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study. Graff GR, Maguiness K, McNamara J, Morton R, Boyd D, Beckmann K, Bennett D. Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415 [Abstract] [Full Text] [Related]
13. Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients. Borowitz D, Goss CH, Stevens C, Hayes D, Newman L, O'Rourke A, Konstan MW, Wagener J, Moss R, Hendeles L, Orenstein D, Ahrens R, Oermann CM, Aitken ML, Mahl TC, Young KR, Dunitz J, Murray FT. Pancreas; 2006 Apr; 32(3):258-63. PubMed ID: 16628080 [Abstract] [Full Text] [Related]
14. The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis. Safdi M, Bekal PK, Martin S, Saeed ZA, Burton F, Toskes PP. Pancreas; 2006 Aug; 33(2):156-62. PubMed ID: 16868481 [Abstract] [Full Text] [Related]
17. Comparison of two forms of enteric-coated pancrelipase In six teenagers with cystic fibrosis. Warwick WJ, Budd JR. Clin Ther; 1982 Jun; 5(1):15-20. PubMed ID: 7127365 [Abstract] [Full Text] [Related]
18. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin. Neoptolemos JP, Ghaneh P, Andrén-Sandberg A, Bramhall S, Patankar R, Kleibeuker JH, Johnson CD. Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419 [Abstract] [Full Text] [Related]